Market Tracker

04/29 5:16pm ET

Cytokinetics Inc (NASDAQ:CYTK)

8.14
Delayed Data
As of Apr 29
 -0.12 / -1.45%
Today’s Change
5.50
Today|||52-Week Range
13.18
-22.18%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close8.26
Today’s open8.23
Day’s range7.99 - 8.33
Volume258,384
Average volume (3 months)386,473
Market cap$327.2M
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-136.59%
Earnings growth (this year)-59.79%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)-38.95%
P/E ratioNM
Price/Sales14.17
Price/Book4.77

Competitors

 Today’s
change
Today’s
% change
LJPCLa Jolla Pharmaceuti...-0.19-1.02%
RIGLRigel Pharmaceutical...-0.05-1.74%
NUTRNutraceutical Intern...-0.58-2.40%
CDTXCidara Therapeutics ...-0.44-3.18%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$28.7M
Annual profit (last year)-$37.5M
Net profit margin-130.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Sharon A. Barbari
Corporate headquarters
South San Francisco, California

Forecasts